Observational studyDiabetes research and clinical practice2021

Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Switzerland multicentre, prospective, observational study.

Gottfried Rudofsky et al.PubMed ↗Publisher ↗

No numbers read from the abstract.